{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-076412","form_type":"8-K","ticker":"LQDA","cik":"0001819576","company_name":"Liquidia Corp","filed_at":"2025-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.120709+00:00","generated_at":"2026-05-17T14:47:59.901869+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Liquidia reports Q2 2025 results: YUTREPIA launch drives $6.5M product revenue, net loss widens","bullets":["YUTREPIA (treprostinil) inhalation powder approved by FDA May 23, 2025; commercial launch in June 2025.","Over 900 unique patient prescriptions and 550 patient starts within 11 weeks post-approval.","ASCENT trial interim: median 6MWD improvement 31.5m at Week 16; median dose 159 mcg QID; no drug-related discontinuations.","Cash $173.4M as of June 30, 2025; product revenue $6.5M in Q2 2025 (first YUTREPIA sales).","Net loss $41.6M ($0.49 per share) vs $28.7M ($0.38) in Q2 2024; SG&A up 95% on commercialization and litigation."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-076412","json":"https://secwatch.observer/filing/0001104659-25-076412.json","markdown":"https://secwatch.observer/filing/0001104659-25-076412.md","text":"https://secwatch.observer/filing/0001104659-25-076412.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819576/000110465925076412/0001104659-25-076412-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819576/000110465925076412/tm2523179d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T14:47:59.901869+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}